Literature DB >> 24730518

Characteristics of gastric cancer according to Helicobacter pylori infection status.

Hee-Won Kwak1, Il Ju Choi, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Myeong-Cherl Kook, Keun Won Ryu, Young-Woo Kim.   

Abstract

BACKGROUND AND AIMS: The definition and incidence of gastric cancer (GC) without Helicobacter pylori (Hp) infection varies between studies. The aim of our study was to compare the characteristics of GC according to Hp infection status.
METHODS: We evaluated the presence of Hp infection in 1833 GC patients with rapid urease tests, serology examinations, and histological evaluations. GC was classified as GC with current Hp infection (HpC-GC), GC with past Hp infection (HpP-GC), and GC not associated with Hp infection (HpN-GC). HpP-GC was defined as GC without current infection but with a positive serology test, glandular atrophy, and/or intestinal metaplasia. HpN-GC was defined as GC with negative Hp test results and no histological changes.
RESULTS: The numbers of HpC-GC, HpP-GC, and HpN-GC were 1378 (75.2%), 412 (22.5%), and 43 (2.3%), respectively. Among GCs without current infection, 90.5% (412/455) were associated with HpP-GC. HpP-GCs were more common in older and male patients, had an increased incidence of synchronous cancer, and less frequently had a diffuse-type histology than HpC-GCs. HpN-GCs were more common in younger, female patients; had a higher proportion of diffuse-type cancers; and more frequently showed distant metastasis than HpP-GCs. In the 40s, the proportion of HpP-GCs with diffuse-type histology (41.9%) was lower than that of HpC-GCs (60.3%) (P = 0.016). The difference was also significant in the 50s (29.1% vs 40.1%, respectively, P = 0.004).
CONCLUSIONS: Most GCs in Korea without current Hp infection showed evidence of past Hp infection. The proportion of GCs with diffuse-type histology decreased in patients with past infection.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Helicobacter pylori; atrophy; gastric cancer; intestinal metaplasia

Mesh:

Year:  2014        PMID: 24730518     DOI: 10.1111/jgh.12605

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

1.  The role of gastric microbiota in gastric cancer.

Authors:  Oliver A Stewart; Fen Wu; Yu Chen
Journal:  Gut Microbes       Date:  2020-05-23

2.  Oral and gastric microbiome in relation to gastric intestinal metaplasia.

Authors:  Fen Wu; Liying Yang; Yuhan Hao; Boyan Zhou; Jiyuan Hu; Yaohua Yang; Sukhleen Bedi; Navin Ganesh Sanichar; Charley Cheng; Guillermo Perez-Perez; Wenche Tseng; Wenzhi Tseng; Mengkao Tseng; Fritz Francois; Abraham R Khan; Yihong Li; Martin J Blaser; Xiao-Ou Shu; Jirong Long; Huilin Li; Zhiheng Pei; Yu Chen
Journal:  Int J Cancer       Date:  2021-11-05       Impact factor: 7.396

3.  Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma.

Authors:  Seungkyung Kang; Miree Park; Jung Yeon Cho; Su Jin Ahn; Changhwan Yoon; Sang Gyun Kim; Soo-Jeong Cho
Journal:  Gastric Cancer       Date:  2022-04-07       Impact factor: 7.701

4.  Germline variants and phenotypic spectrum in a Canadian cohort of individuals with diffuse gastric cancer.

Authors:  M Aronson; C Swallow; A Govindarajan; K Semotiuk; Z Cohen; P Kaurah; L Velsher; I Ambus; K Buckley; C Forster-Gibson; W S Meschino; A Blumenthal; R H Kim; S Brar
Journal:  Curr Oncol       Date:  2020-05-01       Impact factor: 3.677

Review 5.  Endoscopic gastric cancer screening and surveillance in high-risk groups.

Authors:  Il Ju Choi
Journal:  Clin Endosc       Date:  2014-11-30

6.  Therapeutic or spontaneous Helicobacter pylori eradication can obscure magnifying narrow-band imaging of gastric tumors.

Authors:  Masaaki Kobayashi; Satoru Hashimoto; Ken-Ichi Mizuno; Manabu Takeuchi; Yuichi Sato; Gen Watanabe; Yoichi Ajioka; Motoi Azumi; Kouhei Akazawa; Shuji Terai
Journal:  Endosc Int Open       Date:  2016-05-12

7.  Comparison between Resectable Helicobacter pylori-Negative and -Positive Gastric Cancers.

Authors:  Hee Jin Kim; Nayoung Kim; Hyuk Yoon; Yoon Jin Choi; Ju Yup Lee; Yong Hwan Kwon; Kichul Yoon; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Do Joong Park; Hyung Ho Kim; Hye Seung Lee; Dong Ho Lee
Journal:  Gut Liver       Date:  2016-03       Impact factor: 4.519

8.  Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer.

Authors:  Kun-Feng Tsai; Jyh-Ming Liou; Mei-Jyh Chen; Chien-Chuan Chen; Sung-Hsin Kuo; I-Rue Lai; Kun-Huei Yeh; Ming-Tsan Lin; Hsiu-Po Wang; Ann-Lii Cheng; Jaw-Town Lin; Chia-Tung Shun; Ming-Shiang Wu
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

9.  Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study.

Authors:  Saeed Soleyman-Jahi; Afshin Abdirad; Amir Afraz Fallah; Sevil Ghasemi; Fatemeh Sadeghi; Reza Heidari; Habibollah Mahmoodzadeh; Kazem Zendehdel
Journal:  Clin Transl Gastroenterol       Date:  2017-01-05       Impact factor: 4.488

10.  Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.

Authors:  Young-Il Kim; Soo-Jeong Cho; Jong Yeul Lee; Chan Gyoo Kim; Myeong-Cherl Kook; Keun Won Ryu; Young-Woo Kim; Il Ju Choi
Journal:  Cancer Res Treat       Date:  2015-11-17       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.